Almost 7 years ago I was accorded the opportunity of I urge the members of the entire neuroscience community to wish Emilie well in her efforts to take Neuron to being Neuron's first full-time Editor when the journal moved from the University of California, San Francisco, greater heights. In doing so, please continue to send your best research articles, ideas for commentaries, or to Cell Press in Cambridge, Massachusetts. In the able hands of Zach Hall, Lou Reichardt, Jim Hudspeth, Lilly other contributions. In this vein, I will recount a story to help shatter a Jan, and Roger Nicoll, Neuron quickly rose from a fledgling journal in 1988 to become the leading forum for studies widely held misconception of the principal role of a Neuron editor. During a visit with French scientists in Paris, in developmental, cellular, and molecular neurobiology. No less impressive was the breadth and depth of the one of them said that "Neuron is like a chic Parisian night club, and you are the tough bouncer." Although Neuron full-length reviews, commissioned and edited by Eric Kandel and Tom Jessell. flattered by the analogy, I quickly spoke up to correct him. I stated that our role at Neuron was to give authors Due to the desire to understand the neural systems involved in normative brain function and their roles in guidance on what elements make a study appropriate for Neuron and to return quickly those manuscripts that the pathogenesis of neuropsychiatric diseases, I set out to broaden the scope of Neuron to include all areas of do not meet these criteria. We strive to make decisions on manuscripts based on their scientific merits, through neuroscience. Part of this expansion involved focusing on systems neuroscience. When Su Koester joined me an understanding of their content and the critiques made by the referees. Our most rewarding duty is to ensure as Senior Editor, we were able to provide more focused commentaries in the form of minireviews, which complethat paradigm-shifting studies, deemed promising but in need of additional experimental evidence, receive the mented the full-length reviews that Eric Kandel and Tom Jessell continued to provide. Also, we introduced neuroappropriate criticisms to produce the exceptional works that appear in Neuron. Emilie will continue this strong technique papers for cutting-edge methodological studies. By the time that Adina Roskies and Emilie Marcus commitment to fairness and scientific excellence. How can Neuron contribute to some of the greatest joined us at Neuron, we were well on the way to becoming a unique forum for the entire community of neuroscichallenges faced by neuroscience and our society as a whole? Neuroscience will almost certainly be multidiscientists, and systems neuroscience papers began to be featured on Neuron covers at regular intervals. Last year, plinary in the 21 st century. By publishing the major conceptual advances in all areas of neuroscience, Neuron Neuron made a commitment to the publication of important translational research. These clinical and case studhopes to promote and foster the kinds of cross-disciplinary dialogues that will make the new generation of readies have already contributed important insights into human narcolepsy, autoimmune diseases of the nervous ers equally facile in systems and molecular-genetic approaches. As the tools of genetics and functional gesystem, and schizophrenia.
ments more basic approaches to illuminate brain function. We need to understand how the human brain develops and correlate the cognitive stages of development and aging with structural/functional changes in different brain systems. For example, molecular and cellular processes involved in neuronal differentiation, migration, and brain development appear to contribute to the demise of neuronal systems in neurodegenerative diseases. We need to elucidate the genetic, epigenetic, and environmental components that come together to produce the genetically complex neuropsychiatric diseases. We need insights into the pathophysiological processes that often produce common symptoms and impair the circuits that make up the human cognitive and motivational systems. We have to understand how present day pharmacological treatments and cognitivebehavioral therapy cause symptomatic improvements and whether they slow the progression of disease. We need to develop objective criteria, qualitative and quantitative, to assess disease progression and treatment efficacy. This knowledge may allow us to prevent or attenuate the course of these diseases, taking advantage of pharmacogenetics to deliver treatments that take into account the genetic makeup and disease risk of diverse individuals. In the process of this inquiry, we stand to learn a great deal about normative brain function. Although I have focused on understanding disease mechanisms, the confluence of systems and molecular-genetic approaches will provide us with fundamental insights into sensory, motor, and higher cognitive processes.
Should Neuron be involved in shaping public policy as well as education? As textbooks and other reference materials move online, journals will have links to these sources, and education of the more general reader will become one of their mandates. Neuron can shape public policy by providing a forum for discussion of important issues and by helping set guidelines for the biomedical research community. I believe that we need to be guided by strong ethical criteria in our research employing humans and other mammals. In devising the genetic tests to be used in prenatal screening for the genetically complex neuropsychiatric disorders, in targeting stem cells to repair/replace dysfunctional brain systems, and, eventually, in the application of genetic engineering to repair defective genes, we need guidelines that balance science, medicine, and ethics. Equally important, we need to revise our medical and house staff curriculum to build a psychiatry that stands together with neurology and is grounded in systems and behavioral neuroscience. Basic research into normative brain function and dysfunction at several levels will provide the unifying principles and tools necessary to achieve these goals.
We hope that Neuron will continue to serve as a catalyst and intellectual forum for the basic and clinical neuroscience community to achieve these important goals. Bonne chance à Emilie et tous mes amis à Neuron! February 2001 
Gregory Gasic

